Page last updated: 2024-10-20

pyrazinamide and Bowel Diseases, Inflammatory

pyrazinamide has been researched along with Bowel Diseases, Inflammatory in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
" The paradoxical effect observed with probenecid was not seen in the E3040 dose-response curve for the uric acid excretion rate."1.30Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice. ( Furitsu, H; Iga, T; Kotaki, H; Sawada, Y; Yamada, H, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamada, H1
Kotaki, H1
Furitsu, H1
Sawada, Y1
Iga, T1

Other Studies

1 other study available for pyrazinamide and Bowel Diseases, Inflammatory

ArticleYear
Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice.
    Biopharmaceutics & drug disposition, 1999, Volume: 20, Issue:5

    Topics: Animals; Benzothiazoles; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inb

1999